The lower limb amputation risk with the type 2 diabetes drug canagliflozin, the active ingredient in the brand-name drugs Invokana, Invokamet and Invokamet XR, does not apply to other diabetes drugs in its class, according to an Advera Health analysis. Currently, only diabetes medications containing canagliflozin carry black box warnings regarding an increased risk of toe, foot or leg amputations. A boxed warning is the strongest warning issued by the Food and Drug Administration (FDA), and is designed to call attention to serious or life-threatening risks. The FDA’s warning was announced after the agency reviewed data from the CANVAS and ... Read More
Righting Injustice is published by the Beasley Allen Law Firm. If you are interested in a free legal consultation, please take a few moments to fill out the contact form with as many details as possible. The more information you provide us, the better we can evaluate your claim.